LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Sysmex America Exhibits New Products, Automation and Quality Solutions

By LabMedica International staff writers
Posted on 06 Aug 2019
Image: The PS-10, designed for complex laboratory-developed tests and routine flow cytometry applications (Photo courtesy of Sysmex America).
Image: The PS-10, designed for complex laboratory-developed tests and routine flow cytometry applications (Photo courtesy of Sysmex America).
Sysmex America, Inc. (Lincolnshire, IL, USA), a diagnostic solutions company offering hematology, urinalysis and flow cytometry testing technology, exhibited its expanded line of products and services at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo.

At AACC 2019, Sysmex demonstrated its products, processes, automation, quality, and best practices in clinical laboratory management. Sysmex showcased its highly automated and flexible PS-10, which is designed for complex laboratory-developed tests and routine flow cytometry applications, providing clinical laboratories with a new level of workflow efficiency and confidence in accurate results. The PS-10 automates sample preparation, alleviating primary operational bottlenecks in busy clinical flow laboratories, as well as eliminating variability between operators. The PS-10 also offers standardization for antibody cocktailing and reduces the amount of manual transferring of samples performed by laboratory staff.

The company also demonstrated its complete blood count (CBC) analyzer, the XN-20, a complementary system to the XN-10, but with an additional analysis channel. The White Precursor Cell (WPC) channel, which provides improved differentiation of abnormal WBC populations, adds further efficiency for laboratories. Also on display at the tradeshow was the UN-2000, Sysmex’s first fully automated urine particle counter and digital imaging system that provides laboratories with a highly standardized and efficient process for urine sediment analysis, one with less manual intervention and greater accuracy. Using fluorescence flow cytometry, the UN-2000 reduces time consuming hands-on review, delivering highly accurate particle quantitation and differentiation through walk-away loading, standardized criteria with high reproducibility, quantitative measurement and automated validation helping the review of the technologist.

In software solutions, Sysmex demonstrated its quality management system BeyondCare Quality Monitor for Hematology (BCQMh), which streamlines the end-to-end process of running controls and reviewing results, leading to improved analyzer productivity. The web-based quality control and calibration verification management program uses evidence-based quality control. Sysmex also highlighted it powerful software solution Caresphere Laboratory Management (LM) for monitoring quality, productivity and efficiency data, enabling labs to optimize their performance. Bringing together crucial elements such as turnaround times, rerun ratios, analyzer conditions and performance metrics, Caresphere LM provides at-a-glance metrics and status updates designed to give labs the information they need without having to search through multiple software systems. Whether managing one site or many, accessing statistics and calibration data is made simple with Caresphere LM.

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Automatic Hematology Analyzer
DH-800 Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more